Search all medical codes

Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step method

CPT4 code

Name of the Procedure:

Immunoassay for Analyte (Qualitative or Semiquantitative, Multiple Step Method)

  • Common names: Immunoassay, Non-Infectious Analyte Immunoassay
  • Technical terms: Multiple Step Immunoassay, Non-Infectious Agent Analyte Testing

Summary

This type of immunoassay is a laboratory test used to detect the presence or amount of a specific substance (analyte) in a sample through a series of steps that indicates a qualitative (presence/absence) or semiquantitative (approximate amount) result.

Purpose

  • To detect and measure a specific analyte in the body that is not associated with infectious agents.
  • Commonly used to test for hormones, drugs, proteins, and other chemicals in the blood or urine.
  • The goal is to diagnose and monitor various medical conditions or to ensure therapeutic drug levels are within the desired range.

Indications

  • Symptoms or suspicion of hormonal imbalances, drug toxicity, or metabolic disorders.
  • Monitoring therapeutic drug levels in patients on medication.
  • Screening for specific proteins or biomarkers in research or clinical settings.

Preparation

  • Some tests may require fasting, typically for 8-12 hours before sample collection.
  • Patients should inform the healthcare provider of all medications, supplements, and underlying health conditions.
  • Routine diagnostics like blood or urine samples may be collected.

Procedure Description

  1. Sample Collection: Blood is drawn from a vein or a urine sample is collected.
  2. Preparation: The sample is prepared and treated with specific reagents that bind to the target analyte.
  3. Binding: The sample and reagents undergo multiple binding stages wherein a series of reactions occur.
  4. Detection: The final reaction often involves a detectable signal, such as color change, fluorescence, or radioactivity, indicating the presence or quantity of the analyte.
    • Tools/Technology: Microplate readers, spectrophotometers, fluorimeters, or radioimmunoassay counters.
    • Anesthesia/Sedation: Not required.

Duration

  • Typically takes between 1 to 3 hours for the full process, including sample processing and analysis.

Setting

  • Performed in a clinical laboratory or hospital laboratory setting.

Personnel

  • Laboratory technicians or technologists.
  • Pathologists may interpret the results.

Risks and Complications

  • Minimal risk from blood draw: slight bruising, soreness, or very rarely, infection.
  • Incorrect results due to sample contamination or improper handling.

Benefits

  • Provides critical information for diagnosis and treatment management.
  • Results typically available same day or within a few days.
  • Non-invasive with minimal discomfort.

Recovery

  • No recovery time is needed; patients can immediately resume normal activities post-sample collection.
  • Follow-up with healthcare provider to discuss result interpretation and next steps.

Alternatives

  • Other testing methods like mass spectrometry or chromatography.
  • Pros: These may provide more detailed quantitative data.
  • Cons: Often more expensive and time-consuming, requiring specialized equipment and personnel.

Patient Experience

  • During: Brief discomfort during blood draw; otherwise no pain or discomfort.
  • After: Minimal to no side effects; routine care for the blood draw site as recommended in everyday blood collection such as applying a bandage.

Similar Codes